Meningococcal Vaccine Development To Get FDA Advisory Cmte. Review
• By The Pink Sheet Daily
Although it's announced as a scientific discussion on immunological markers, the April 6 meeting will have large implications for Menveo and Menactra's applications to expand their indications into infants.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
